Dr. Amaria on Genetically Modified TILs in Melanoma

1 Mga view
administrator
administrator
07/03/23

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

  • Kategorya

Magpakita ng higit pa

0 Mga komento Pagbukud-bukurin Ayon

Walang nakitang komento

Mga Komento sa Facebook

Susunod